Merck KGaA (OTCMKTS:MKKGY – Get Free Report) will likely be releasing its results before the market opens on Thursday, November 13th. Analysts expect Merck KGaA to post earnings of $0.50 per share for the quarter.
Merck KGaA Stock Up 2.7%
OTCMKTS:MKKGY opened at $26.18 on Wednesday. The company has a market cap of $16.92 billion, a price-to-earnings ratio of 11.00, a P/E/G ratio of 3.23 and a beta of 0.96. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.78 and a current ratio of 1.24. The stock’s fifty day moving average price is $26.22 and its two-hundred day moving average price is $26.22. Merck KGaA has a 52-week low of $24.32 and a 52-week high of $32.43.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on MKKGY shares. Barclays lowered Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 19th. Zacks Research upgraded shares of Merck KGaA to a “hold” rating in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold”.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Investing in the High PE Growth Stocks
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- How to Buy Cheap Stocks Step by Step
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
